Seven-time Super Bowl champion Tom Brady is proving that his skills also translate perfectly in the boardroom. In a major career move that has set the business world buzzing, the NFL legend has helped secure a $200 million Series A funding round for the digital health startup eMed.
The massive capital injection has officially propelled the Miami-based company to a valuation of over $2 billion, solidifying its status as a unicorn in the healthcare tech space.
Brady shared a post by "fittinsider" on his story, commenting "💪🏻💪🏻💪🏻LOADING!!!" Brady isn’t just a passive investor in this venture, he has taken on the active role of Founding Chief Wellness Officer.
This move marks a strategic expansion of his post-retirement empire, which already includes a $375 million broadcasting deal with Fox Sports and minority ownership stakes in the Las Vegas Raiders and Birmingham City FC.
The $200 million funding round was led by AON Consulting and included other high-profile figures like eMed CEO Linda Yaccarino (former CEO of X). The company has recently pivoted toward a high-growth market: managing GLP-1 weight-loss medications for employers. Brady’s involvement is centered on eMed’s platform, which aims to improve patient adherence and lower the skyrocketing costs of obesity and diabetes treatments.
"I believe eMed’s empathic agentic AI platform represents a true winning formula. That conviction is why I’ve chosen to invest both my time and my capital." Brady shared in a recent statement to PYMNTS.
With this latest $200 million milestone, Brady’s total off-field career earnings—including endorsements and his Fox contract—are projected to push his personal net worth toward the billionaire mark by the end of the decade.
